» Authors » Anne-Marie Laberge

Anne-Marie Laberge

Explore the profile of Anne-Marie Laberge including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 575
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Khatami N, Caraus I, Rahaman M, Nepotchatykh E, Elbakry M, Elremaly W, et al.
Sci Rep . 2025 Feb; 15(1):5305. PMID: 39939711
Adolescent Idiopathic Scoliosis (AIS) is the most common orthopedic condition requiring surgery, affecting 4% of adolescents. There is currently no proven method or prognostic test to identify symptomatic patients at...
2.
Roy M, Malo M, Morel-Laforce T, Ravitsky V, Laberge A
Prenat Diagn . 2025 Jan; PMID: 39891168
Objective: To explore decision makers' perspectives on the conditions for a responsible implementation of non-invasive prenatal testing (NIPT) as a first-tier test in Canadian provinces' healthcare systems. Method: A qualitative...
3.
Laforce T, Laberge A, Malo M, Ravitsky V
Prenat Diagn . 2025 Jan; 45(2):163-170. PMID: 39763198
Objective: Advancements in non-invasive prenatal screening (NIPS) could significantly alter prenatal screening by expanding the range of genetic conditions screened. This study aims to explore the perspectives of healthcare professionals...
4.
Richer J, Velchev J, Goobie S, Boswell-Patterson C, van de Laar I, Verhagen J, et al.
J Med Genet . 2025 Jan; 62(3):199-205. PMID: 39746778
Background: Individuals harbouring pathogenic variants are at risk for aneurysms/dissections throughout the arterial tree. Based on prior reports of sex differences in thoracic aortic aneurysm/dissection, we investigated the sexual dimorphism...
5.
Goudie C, Zawati M, Knoppers B, Laberge A
J Med Genet . 2024 Dec; 62(2):138-146. PMID: 39653388
Background: This study explores the ethical and moral challenges faced by paediatric oncologists when they are informed of patient genomic results, particularly during molecular tumour boards (MTBs), highlighting the interplay...
6.
Gallois H, Ravitsky V, Roy M, Laberge A
Eur J Hum Genet . 2024 Oct; 33(2):167-175. PMID: 39462080
We hypothesized that ethical criteria that guide the use of preimplantation genetic testing (PGT) could be used to inform policies about expanded use of non-invasive prenatal screening (NIPS). We used...
7.
Goh E, Chad L, Richer J, Bombard Y, Mighton C, Agatep R, et al.
J Med Genet . 2024 Oct; 61(12):1123-1131. PMID: 39362754
Background: Advances in technology and knowledge have facilitated both an increase in the number of patient variants reported and variants reclassified. While there is currently no duty to recontact for...
8.
DAmours G, Clausen M, Luca S, Reble E, Kodida R, Assamad D, et al.
BMJ Open . 2024 Sep; 14(9):e090084. PMID: 39231549
Introduction: Genetic testing is used across medical disciplines leading to unprecedented demand for genetic services. This has resulted in excessive waitlists and unsustainable pressure on the standard model of genetic...
9.
Knoppers B, Bonilha A, Laberge A, Ahmed A, Newson A
Eur J Hum Genet . 2024 Aug; 33(2):182-188. PMID: 39134767
In this paper, we explore key aspects of the complex ethical and legal landscape surrounding consent in the context of incorporating genomic sequencing into existing newborn bloodspot screening programs. In...
10.
Kleiderman E, Boardman F, Newson A, Laberge A, Knoppers B, Ravitsky V
Eur J Hum Genet . 2024 Aug; 33(2):158-166. PMID: 39127803
The notion of a "serious" genetic condition is commonly used in clinical contexts, laws, and policies to define and delineate both the permissibility of and, access to, reproductive genomic technologies....